comparemela.com

Latest Breaking News On - Director dawn svoronos - Page 1 : comparemela.com

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Acquired by Moran Wealth Management LLC

Moran Wealth Management LLC grew its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 1.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,930 shares of the biopharmaceutical company’s stock after purchasing an additional 1,317 shares during the period. […]

Arizona
United-states
Canada
Montreal
Quebec
Xenon-pharmaceuticals-company-profile
Nasdaq
Xenon-pharmaceuticals-inc
Quarter-for-xenon-pharmaceuticals
Moran-wealth-management
Exchange-commission

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
China
Wells-fargo-company
Nasdaq
Hedge-funds-weigh-in-on-xenon-pharmaceuticals
Securities-exchange-commission
Needham-company
Xenon-pharmaceuticals-stock-performance
News-ratings-for-xenon-pharmaceuticals-daily
Royal-bank
China-universal-asset-management-co

Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)

Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
Royal-bank
Xenon-pharmaceuticals-inc
Cantor-fitzgerald
News-ratings-for-xenon-pharmaceuticals-daily
Xenon-pharmaceuticals
Needham-company
Institutional-trading-of-xenon-pharmaceuticals
Driehaus-capital-management
Securities-exchange-commission
Xenon-pharmaceuticals-stock-performance

Xenon Pharmaceuticals (NASDAQ:XENE) Hits New 52-Week Low at $30.91

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) hit a new 52-week low on Thursday . The company traded as low as $30.91 and last traded at $31.13, with a volume of 353275 shares. The stock had previously closed at $32.95. Analyst Ratings Changes A number of equities analysts have recently weighed in on XENE […]

Blackrock
Nova-scotia
Canada
Needham-company
Cantor-fitzgerald
Jpmorgan-chase-co
News-ratings-for-xenon-pharmaceuticals-daily
Institutional-investors-weigh-in-on-xenon-pharmaceuticals
Xenon-pharmaceuticals-inc
Blackrock-inc
Royal-bank

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives $52.40 Average PT from Analysts

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives $52.40 Average PT from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Royal-bank
Institutional-trading-of-xenon-pharmaceuticals
Needham-company
Securities-exchange-commission
Cantor-fitzgerald
News-ratings-for-xenon-pharmaceuticals-daily
Xenon-pharmaceuticals
Wells-fargo-company
Advisors-asset-management-inc
Xenon-pharmaceuticals-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.